Read more about the article EU–India Free Trade Agreement: Impact on Medical Device Imports, Costs, and Market Access in India
EU–India FTA Impact on Medical Device Imports in India

EU–India Free Trade Agreement: Impact on Medical Device Imports, Costs, and Market Access in India

The ongoing negotiations around the EU–India Free Trade Agreement (FTA) mark a potentially important inflexion point for India’s medical device market. While the agreement is still being finalised, its direction…

Continue ReadingEU–India Free Trade Agreement: Impact on Medical Device Imports, Costs, and Market Access in India
Read more about the article India’s Antibiotic Innovators: Orchid, Wockhardt and Bugworks at the Frontline of AMR
India antibiotic innovation Orchid Wockhardt Bugworks

India’s Antibiotic Innovators: Orchid, Wockhardt and Bugworks at the Frontline of AMR

A crisis with few champions Antibiotics transformed modern medicine — from safe childbirth to organ transplants — yet their power is slipping away. Antimicrobial resistance (AMR) now kills more than…

Continue ReadingIndia’s Antibiotic Innovators: Orchid, Wockhardt and Bugworks at the Frontline of AMR

Biological E study finds PNEUBEVAX 14TM Vaccine Safe and effective in Infants

Biological E. Limited (BE), a Hyderabad-based Vaccine and Pharmaceutical Company, today announced the publication of Phase-III clinical trial results of BE's 14-Valent Pneumococcal Conjugate Vaccine (PCV) (PNEUBEVAX 14TM; BE-PCV-14) conducted…

Continue ReadingBiological E study finds PNEUBEVAX 14TM Vaccine Safe and effective in Infants

Study in Hungary finds that Deuterium depletion is the key to getting a breakthrough in cancer therapy

HYD LLC for Cancer Research and Drug Development (HYD or the Company) today announces two independent review papers in Nutrients -  Deuterium-Depleted Water in Cancer Therapy: A Systematic Review of…

Continue ReadingStudy in Hungary finds that Deuterium depletion is the key to getting a breakthrough in cancer therapy

Aedesius Health partners with Indegene for a comprehensive commercialization engagement

Aedesius Health, a division of AedesiusOne Ltd, and its biopharmaceutical development incubator AO BIO, which is focused on developing and commercializing neglected and needed therapies, devices, and diagnostics, today announced…

Continue ReadingAedesius Health partners with Indegene for a comprehensive commercialization engagement